Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
Adult
Black or African American
/ statistics & numerical data
Aged
Aged, 80 and over
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ statistics & numerical data
Cohort Studies
Coronavirus Infections
/ diagnosis
Ethnicity
/ statistics & numerical data
Female
Hispanic or Latino
/ statistics & numerical data
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral
/ diagnosis
Retrospective Studies
SARS-CoV-2
United States
/ epidemiology
Veterans
/ statistics & numerical data
White People
/ statistics & numerical data
Young Adult
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
11
06
2020
accepted:
31
08
2020
entrez:
22
9
2020
pubmed:
23
9
2020
medline:
2
10
2020
Statut:
epublish
Résumé
There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19). We investigated racial and ethnic disparities in patterns of COVID-19 testing (i.e., who received testing and who tested positive) and subsequent mortality in the largest integrated healthcare system in the United States. This retrospective cohort study included 5,834,543 individuals receiving care in the US Department of Veterans Affairs; most (91%) were men, 74% were non-Hispanic White (White), 19% were non-Hispanic Black (Black), and 7% were Hispanic. We evaluated associations between race/ethnicity and receipt of COVID-19 testing, a positive test result, and 30-day mortality, with multivariable adjustment for a wide range of demographic and clinical characteristics including comorbid conditions, health behaviors, medication history, site of care, and urban versus rural residence. Between February 8 and July 22, 2020, 254,595 individuals were tested for COVID-19, of whom 16,317 tested positive and 1,057 died. Black individuals were more likely to be tested (rate per 1,000 individuals: 60.0, 95% CI 59.6-60.5) than Hispanic (52.7, 95% CI 52.1-53.4) and White individuals (38.6, 95% CI 38.4-38.7). While individuals from minority backgrounds were more likely to test positive (Black versus White: odds ratio [OR] 1.93, 95% CI 1.85-2.01, p < 0.001; Hispanic versus White: OR 1.84, 95% CI 1.74-1.94, p < 0.001), 30-day mortality did not differ by race/ethnicity (Black versus White: OR 0.97, 95% CI 0.80-1.17, p = 0.74; Hispanic versus White: OR 0.99, 95% CI 0.73-1.34, p = 0.94). The disparity between Black and White individuals in testing positive for COVID-19 was stronger in the Midwest (OR 2.66, 95% CI 2.41-2.95, p < 0.001) than the West (OR 1.24, 95% CI 1.11-1.39, p < 0.001). The disparity in testing positive for COVID-19 between Hispanic and White individuals was consistent across region, calendar time, and outbreak pattern. Study limitations include underrepresentation of women and a lack of detailed information on social determinants of health. In this nationwide study, we found that Black and Hispanic individuals are experiencing an excess burden of SARS-CoV-2 infection not entirely explained by underlying medical conditions or where they live or receive care. There is an urgent need to proactively tailor strategies to contain and prevent further outbreaks in racial and ethnic minority communities.
Sections du résumé
BACKGROUND
There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19). We investigated racial and ethnic disparities in patterns of COVID-19 testing (i.e., who received testing and who tested positive) and subsequent mortality in the largest integrated healthcare system in the United States.
METHODS AND FINDINGS
This retrospective cohort study included 5,834,543 individuals receiving care in the US Department of Veterans Affairs; most (91%) were men, 74% were non-Hispanic White (White), 19% were non-Hispanic Black (Black), and 7% were Hispanic. We evaluated associations between race/ethnicity and receipt of COVID-19 testing, a positive test result, and 30-day mortality, with multivariable adjustment for a wide range of demographic and clinical characteristics including comorbid conditions, health behaviors, medication history, site of care, and urban versus rural residence. Between February 8 and July 22, 2020, 254,595 individuals were tested for COVID-19, of whom 16,317 tested positive and 1,057 died. Black individuals were more likely to be tested (rate per 1,000 individuals: 60.0, 95% CI 59.6-60.5) than Hispanic (52.7, 95% CI 52.1-53.4) and White individuals (38.6, 95% CI 38.4-38.7). While individuals from minority backgrounds were more likely to test positive (Black versus White: odds ratio [OR] 1.93, 95% CI 1.85-2.01, p < 0.001; Hispanic versus White: OR 1.84, 95% CI 1.74-1.94, p < 0.001), 30-day mortality did not differ by race/ethnicity (Black versus White: OR 0.97, 95% CI 0.80-1.17, p = 0.74; Hispanic versus White: OR 0.99, 95% CI 0.73-1.34, p = 0.94). The disparity between Black and White individuals in testing positive for COVID-19 was stronger in the Midwest (OR 2.66, 95% CI 2.41-2.95, p < 0.001) than the West (OR 1.24, 95% CI 1.11-1.39, p < 0.001). The disparity in testing positive for COVID-19 between Hispanic and White individuals was consistent across region, calendar time, and outbreak pattern. Study limitations include underrepresentation of women and a lack of detailed information on social determinants of health.
CONCLUSIONS
In this nationwide study, we found that Black and Hispanic individuals are experiencing an excess burden of SARS-CoV-2 infection not entirely explained by underlying medical conditions or where they live or receive care. There is an urgent need to proactively tailor strategies to contain and prevent further outbreaks in racial and ethnic minority communities.
Identifiants
pubmed: 32960880
doi: 10.1371/journal.pmed.1003379
pii: PMEDICINE-D-20-02701
pmc: PMC7508372
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003379Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Commentaires et corrections
Type : UpdateOf
Type : UpdateOf
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Am J Public Health. 2018 Mar;108(3):e1-e11
pubmed: 29412713
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Lancet. 2020 May 2;395(10234):1421-1422
pubmed: 32330427
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
J Rural Health. 2010 Fall;26(4):310-7
pubmed: 21029165
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
medRxiv. 2020 Apr 14;:
pubmed: 32511595
Disasters. 1999 Jun;23(2):156-73
pubmed: 10379098
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
BMJ Open. 2020 Aug 11;10(8):e039849
pubmed: 32784264
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Am J Prev Med. 2012 May;42(5):473-80
pubmed: 22516487
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):933-937
pubmed: 32673303
Arch Intern Med. 2000 Jul 10;160(13):1977-89
pubmed: 10888972
Ann Epidemiol. 2020 Dec;52:46-53.e2
pubmed: 32711053
Rand Health Q. 2016 May 9;5(4):13
pubmed: 28083423
Am J Prev Med. 2012 Nov;43(5):483-9
pubmed: 23079170
Am J Public Health. 2009 Oct;99 Suppl 2:S261-70
pubmed: 19797739
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758